Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SRDX crawled time : 13:00 save search
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -1.06%
H: 3.24%
C: 0.95%
report financial results
Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium
Published: 2023-11-07 (Crawled : 13:00) - biospace.com/
ABT | News | $107.515 0.42% 2.4M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: 0.69%
H: 1.71%
C: 0.95%
symposium trial transcend
Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15
Published: 2023-11-07 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: 0.69%
H: 1.71%
C: 0.95%
symposium trial
Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
Published: 2023-01-19 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -27.61%
H: 15.21%
C: -2.4%
fda application approval update
Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance
Published: 2022-11-09 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -2.04%
H: 0.21%
C: -4.67%
year financial
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
Published: 2022-11-02 (Crawled : 13:00) - biospace.com/
ABT | News | $107.515 0.42% 2.4M
|
Health Technology
|
| O: -0.58%
H: 2.53%
C: -0.7%
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -0.77%
H: 8.9%
C: 4.92%
conference trial transcend
Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
ABT | News | $107.515 0.42% 2.4M
|
Health Technology
|
| O: 0.14%
H: 1.46%
C: 0.34%
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: 1.29%
H: 3.22%
C: 1.97%
trial transcend
6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe
Published: 2022-10-11 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -0.63%
H: 3.43%
C: 1.64%
europe trial
Surmodics to Webcast Third Quarter Fiscal 2022 Earnings Conference Call on July 27
Published: 2022-07-19 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: 1.68%
H: 3.27%
C: 2.6%
conference
Dr. Gary Ansel to Present Pounce™ Thrombectomy System First-in-Human Data at Charing Cross Symposium
Published: 2022-04-25 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -6.87%
H: 3.52%
C: 0.84%
system symposium
Surmodics to Webcast Second Quarter Fiscal 2022 Earnings Conference Call on April 27
Published: 2022-04-19 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: 0.14%
H: 4.29%
C: 3.61%
conference
Global Hydrophilic Coating Market Size | 2022 - 2028 | Component and Application | Hit to USD 18.59 Billion By 2028: Zion Market Research
Published: 2022-03-24 (Crawled : 13:00) - prnewswire.com
TFX | $211.14 1.87% 180K
|
Health Technology
|
| O: 0.47%
H: 2.11%
C: 1.19%
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: 0.19%
H: 1.14%
C: 1.14%
application research market
Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance
Published: 2021-11-10 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -5.56%
H: 1.48%
C: -5.56%
results
Surmodics to Webcast Fourth Quarter Fiscal 2021 Earnings Conference Call on November 10
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -1.43%
H: 0.42%
C: -1.06%
conference
Surmodics Announces Successful First Patient Uses of Sublime™ Radial Access .018 RX PTA Dilatation Catheter
Published: 2021-09-29 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: 0.96%
H: 1.19%
C: 0.95%
Surmodics Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance
Published: 2021-08-04 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -1.19%
H: 2.12%
C: -1.74%
results ev
Surmodics Builds Thrombectomy Portfolio with Acquisition of Vetex Medical Limited
Published: 2021-07-06 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -3.7%
H: 0.59%
C: -1.16%
acquisition
Surmodics Reports Second Quarter Fiscal 2021 Results and Issues Fiscal 2021 Revenue and EPS Guidance
Published: 2021-04-28 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: 0.37%
H: 0.98%
C: -0.12%
results ev
Surmodics to Webcast Second Quarter Fiscal 2021 Earnings Conference Call on April 28
Published: 2021-04-20 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: -0.63%
H: 2.63%
C: 0.89%
conference
Surmodics Reports First Quarter Fiscal 2021 Results
Published: 2021-02-09 (Crawled : 13:00) - biospace.com/
SRDX | $26.655 4.98% 29K
|
Health Technology
|
| O: 2.05%
H: 16.16%
C: 11.68%
results report
Gainers vs Losers
| 85% | 15% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.99 139.2% 64M
|
Finance
CZOO | $8.67 73.75% 23M
|
EDBL | News | $6.47 72.07% 1.9M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7989 33.15% 3.2M
|
Health Technology
BTCM | $3.51 30.0% 730K
|
Arts, Entertainment, and Recrea...
MLEC | $1.81 29.29% 2.8M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.